Tesamorelin + Ipamorelin Blend 10mg / 3mg
€ 99,00
Tesamorelin + Ipamorelin Blend 13 mg – Grail Formula Quality.
Includes Tesamorelin 10 mg and Ipamorelin 3 mg.
Independently verified to exceed 99 percent purity.
Validated for identity, structural integrity and stability across both components.
Supplied as a 13 mg lyophilized dual-peptide blend with full quality verification.
Within Europe this product is supplied including bacteriostatic water; outside the EU only the vials are provided.
For research use only — not for human or veterinary use.
Availability: In stock: ships within 1 day after payment confirmation.
Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vials are provided.
For research use only – not for human or veterinary use.
Product Overview
This Tesamorelin + Ipamorelin Blend (10 mg / 3 mg) is a dual-peptide research system designed for in-vitro modelling of growth-hormone signalling pathways, receptor-associated modulation and biochemical communication patterns. Each peptide contributes a distinct mechanistic profile, enabling comparative or synergistic evaluation of GH-axis regulatory processes under controlled laboratory conditions.
Peptide Overview
Tesamorelin entered scientific literature during the early 2000s as part of a broader investigative effort into growth-hormone–releasing regulatory peptides. Between 2005 and 2020 it became a widely referenced compound in mechanistic studies involving GH-pathway signalling, structural–function evaluation and biochemical modulation.
Ipamorelin was characterised in the late 1990s and rapidly gained prominence due to its receptor-selective signalling behaviour. From 2000 to 2025 Ipamorelin has been used extensively in modelling selective GH-axis responses, providing researchers with a consistent and analytically stable reference molecule.
Historical Background and Scientific Context
From 1995 onward, research into GH-axis modulation expanded considerably as laboratories examined receptor-guided cascades, signalling mechanisms and intracellular communication pathways.
Between 2015 and 2025 dual-peptide systems like Tesamorelin + Ipamorelin became increasingly relevant as part of advanced comparative pathway modelling. Combining two mechanistically distinct peptides facilitates evaluation of differential receptor activity, biochemical signalling behaviour and structure–function interaction patterns under controlled experimental conditions.
Mechanistic Focus in Research
- Growth-hormone signalling and receptor-modulation modelling
- Structure–function evaluation across dual-peptide systems
- Comparative mechanistic analysis of regulatory peptide pathways
- Biochemical cascade modelling under controlled conditions
- Intracellular communication and pathway-response profiling
Quality Verification
All peptides within this blend are independently verified to exceed 99 percent purity. Each vial undergoes analytical assessment for identity, structural integrity and stability using validated laboratory methodologies.
When You Choose Grail Formula…
Researchers receive high-purity peptides with sealed-vial integrity, verified identity and guaranteed purity above 99 percent. EU shipments include sterile bacteriostatic water; outside Europe only the peptide vials are supplied.
For research use only – not for human or veterinary use.
- Dual-peptide blend: Tesamorelin 10 mg + Ipamorelin 3 mg
- Both peptides independently verified to exceed 99 percent purity
- Designed for GH-axis signalling and pathway-modelling research
- Reproducible analytical behaviour in in-vitro environments
- EU shipments include bacteriostatic water
- For research use only – not for human or veterinary use
For laboratory research only. Not intended for human consumption, injection, or cosmetic use.
This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.
